Co-trimoxazole tablets, the main indication for this product is susceptible strains of the following infections.
(1) Urinary tract infections caused by sensitive strains of Escherichia coli, Klebsiella, Enterobacter, Proteus mirabilis, Proteus vulgaris and Morrhiza.
(2) Acute otitis media in children over 2 years old caused by streptococcus pneumoniae or haemophilus influenzae.
(3) Acute onset of chronic bronchitis in adults caused by Streptococcus pneumoniae or Haemophilus influenzae.
(4) Intestinal infection and shigella infection caused by sensitive strains of Fowleri or Shigella Soong.
(5) Treatment of Pneumocystis carinii pneumonia, this strain is preferred.
(6) Prevention of pneumocystis carinii pneumonia can be used in patients with at least one history of pneumocystis carinii disease, or in adults infected with HIV, whose CD4 lymphocyte count is ≤200/mm3 or less than 20% of the total lymphocyte count.
(7) Tourist diarrhea caused by enterotoxigenic Escherichia coli (ETEC).
Audited Supplier 
){kind=link}